<DOC>
	<DOC>NCT02911545</DOC>
	<brief_summary>Non-vitamin K oral anticoagulants (NOAC) have been shown to be safe and effective alternatives to warfarin for stroke prevention in patients with nonvalvular AF (NVAF). There are yet limited real life data on outcomes following elective cardioversion in AF patients treated with NOACs. The aim of this study is to investigate the complications and the use of NOACs in AF patients undergoing cardioversion.</brief_summary>
	<brief_title>Non-vitamin K Oral Anticoagulants in Cardioversion</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>AF patients undergoing cardioversion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Anticoagulation</keyword>
	<keyword>Cardioversion</keyword>
</DOC>